A new device for meibomian gland debridement was safe and effective and demonstrated time and space benefits compared with conventional debridement and expression approaches, according to a study ...

Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a ...

Carolyn Adelsten woke up feeling like something was in her eye and it wouldn't come out. She visited an eye specialist, got a diagnosis of mild dry eye disease and was told to ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. One ...

Bleakley Financial Group LLC bought a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 5,825 shares ...

OT presents a clinical scenario to three of its resident IP optometrists. Here, a 40-year-old with dry eye disease and an adverse reaction to prescribed eye drops ...

Researchers conducted a study to characterize ophthalmic adverse events associated with cosmetics and personal care products ...

AZR-MD-001, met its primary endpoints of showing improvements in both the signs and symptoms of dry eye disease caused by Meibomian gland dysfunction (MGD) reaching statistical significance ...

NOV03 is being reviewed as a treatment for the signs and symptoms of dry eye disease associated with Meibomian gland dysfunction (MGD), a group which is estimated to account for the majority ...

Shtein: Wearing glasses, especially those with side shields, can help protect you in windy environments. Over-the-counter eye ...

(WIFR) - Researchers at the University of Wisconsin are testing a groundbreaking cell therapy for Sjögren’s disease, a complex autoimmune disorder that is difficult to treat. The trial focuses on ...